Israel Monitors Suspected Ebola Case as Bundibugyo Outbreak Spreads Across Central Africa

Israel's Health Ministry is actively monitoring a suspected case of Ebola virus disease (搜索)搜索该疾病 after a traveler who returned from the Democratic Republic of Congo (DRC) three days ago began exhibiting early symptoms of infection, the ministry announced on Friday. The individual developed fever and headache — common initial symptoms of the virus — and has been transferred to Rambam Health Care Campus查看公司主页, which has been designated as the medical center for such cases, where they remain in isolation under standard protocols.

The ministry stressed that the findings remain a matter of suspicion only, with tests underway and results expected within 24 to 48 hours. An epidemiological investigation has been launched to trace contacts. "As part of the preparedness, professional guidelines have been distributed to medical teams and relevant hospitals to handle suspected cases," the ministry stated.

Outbreak Scale and Global Response

The current outbreak, caused by the Bundibugyo virus (搜索)搜索该疾病, was declared on May 15 in the DRC after the virus was identified in Ituri Province in the northeastern part of the country. Two days later, WHO Director-General Dr. Tedros Adhanom Ghebreyesus declared the situation a public health emergency of international concern, citing the rate of spread, cross-border transmission, and the difficulty of interrupting chains of infection.

According to the US Centers for Disease Control and Prevention (搜索)搜索该词条, there are 933 confirmed cases and 245 confirmed deaths in the DRC, alongside 19 confirmed cases and two confirmed deaths in Uganda. Cases have been identified across 24 health zones in three provinces: Ituri, North Kivu, and South Kivu. In Uganda, some patients were infected in Congo and crossed the border, while Uganda has also documented infections linked to contact with patients and to medical care.

One patient, a resident of Congo, stayed in the United Arab Emirates before arriving in Uganda. The WHO stated it is working with health authorities in both countries to determine whether additional travelers were exposed during the journey. An American physician who became infected while treating patients in Congo was transported in isolation to Germany and was discharged from a hospital in Berlin on Sunday after recovering.

No Approved Vaccine for Bundibugyo Strain

Unlike the Zaire strain of Ebola, for which vaccines and targeted treatments exist, there is currently no approved vaccine or specific antiviral treatment for the Bundibugyo virus (搜索)搜索该疾病. Treatment is based primarily on fluid administration, correction of electrolyte imbalances, support for blood pressure and body systems, and treatment of accompanying infections or complications.

The WHO's risk assessment remains unchanged: very high risk within the DRC, high risk for countries in the region, and low risk globally. However, contact tracing in Congo remains incomplete. By early June, only about 45% of patient contacts had been identified, whereas monitoring more than 90% is required to effectively interrupt chains of transmission. Armed conflict, refugee movements, open land borders, and mistrust of authorities among some communities are complicating tracing and isolation efforts.

Israel's Preparedness Measures

Israel's Health Ministry has been preparing hospitals, medical teams, and public health systems following the outbreak. The ministry believes the risk of an Ebola outbreak in Israel remains low, but the rapid spread in the DRC and the arrival of patients in Uganda, the UAE, and Germany have led to increased monitoring and emergency preparations.

Specialized equipment has already been distributed to hospitals, including protective suits and equipment intended for treating highly infectious diseases. The ministry is also advancing the establishment of dedicated facilities to treat cases suspected of a dangerous infectious disease. Professional guidelines for medical teams and relevant hospitals are expected to be published in the coming days, covering criteria for defining a suspected case, procedures for staff protection, patient isolation, sample collection, transfer of samples to laboratories, and reporting to public health authorities.

The ministry has established early detection mechanisms for travelers returning from affected areas and set up a laboratory detection system for Ebola infection. Travelers returning from active Ebola areas who develop fever or unusual symptoms within 21 days of return — the generally accepted maximum incubation period — are requested to stay home, avoid contact with others, and contact the Health Ministry's Health Voice Call Center by phone at *5400.

Travel Advisories and Transmission

The Health Ministry recommends avoiding non-essential travel to the DRC and Uganda, particularly to areas with active transmission. This recommendation is notably stricter than the WHO's position, which states there is currently no justification for broad restrictions on travel or trade with Congo and Uganda. The difference stems from a more cautious approach toward travel that can be postponed rather than a higher risk assessment for Israel.

Ebola is not generally transmitted through the air like measles, influenza, or COVID-19. An infected person is not considered contagious before symptoms appear, and infection can only occur through direct contact with a sick person with symptoms or with bodily fluids.

US infectious disease experts have emphasized that the risk of infection for travelers remains very low. "We're not going to be able to prevent 100% of infections, but we certainly are the most prepared that we have ever been," said Dr. Gavin Harris, an expert in serious communicable diseases at Emory University in Atlanta.

The ministry reiterated that there are still no confirmed cases of Ebola in Israel and stated that no action is required by the public unless contacted specifically by the Health Ministry.